Compound Summary
药名: | silymarin |
别名: | AC-20318; AKOS015965311; silymarin |
分子式: | C25H22O10 |
Smiles: | COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)C4C(C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O |
成分: | HBIN044040 |
SymMap_id: | SMIT18310 |
TCMID_id: | 23141 |
PubChem_id: | 24832061 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE001911 | Herba Acalyphae | 铁苋菜 | 1. Treatment of diarrhea and dysentery of darnpness-heat type. Recently, also for amebic dysentery and typhoid fever. 2. Treatment of hemoptysis, hematemesis, hemafecia, metrorrhagia, etc. 3. Treatment of dyspneic cough of lung-heat type./1. Bacteriostatic. 2. Astringent and protective on intestinal mucosa. 3. Antiasthmatic. | |||
TCMBANKHE001959 | 白花水飞蓟 | |||||
TCMBANKHE006366 | Radix Moghaniae Philippinensis | 千斤拔 | ||||
TCMBANKHE006357 | 水飞蓟 | Acute hepatitis, chronic hepatitis, cirrhosis, fatty liver, gallstones, cholangitis. | ||||
TCMBANKHE001493/XU-632 | Folium Pini|Pinus massoniana | 松针|马尾松 | 吉林省白山市抚松县 | 1. To tranquilize the mind. For palpitation, insomnia, amnesia. Recently used for neurasthenia, chronic Keshan disease, hypertension, coronary heart diseases and cor pulmonale. 2. External use for depriving dampness, killing parasite and alleviate itching. For exudative dermatitis, scabies and tinea./1. To tranquilize the mind. For palpitation, insomnia, amnesia. Recently used for neurasthenia, chronic Keshan disease, hypertension, coronary heart diseases and cor pulmonale. 2. External use for depriving dampness, killing parasite and alleviate itching |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
TCMBANKDI000019 | Parkinson Disease | disease | Nervous System Diseases | 20964710 |
TCMBANKDI000026 | Obesity | disease | Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 28625483 |
TCMBANKDI000081 | Diabetes Mellitus, Experimental | disease | Nutritional and Metabolic Diseases; Endocrine System Diseases | 20578796 |
TCMBANKDI000085 | Inflammation | phenotype | Pathological Conditions, Signs and Symptoms | 20578796 |
TCMBANKDI002231 | Cholestasis | disease | Digestive System Diseases | 24819445 |
TCMBANKDI006257 | Biliary cirrhosis | disease | Pathological Conditions, Signs and Symptoms; Digestive System Diseases | 24819445 |
TCMBANKDI012770 | Altitude Sickness | phenotype | Respiratory Tract Diseases | 27105952 |
TCMBANKDI013453 | Proteinuria | phenotype | Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 22770926 |
TCMBANKDI023555 | Hypoxia | phenotype | Pathological Conditions, Signs and Symptoms | 27105952 |
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000051 | IL1B | IL-1; IL1-BETA; IL1F2; IL1beta | interleukin 1 beta |
TCMBANKGE000052 | TNF | DIF; TNF-alpha; TNFA; TNFSF2; TNLG1F | tumor necrosis factor |
TCMBANKGE000199 | ICAM1 | BB2; CD54; P3.58 | intercellular adhesion molecule 1 |
TCMBANKGE000204 | CXCL8 | GCP-1; GCP1; IL8; LECT; LUCT; LYNAP; MDNCF; MONAP; NAF; NAP-1; NAP1; SCYB8 | C-X-C motif chemokine ligand 8 |
TCMBANKGE000298 | SOD1 | ALS; ALS1; HEL-S-44; IPOA; SOD; STAHP; hSod1; homodimer | superoxide dismutase 1 |
TCMBANKGE000315 | IL4 | BCGF-1; BCGF1; BSF-1; BSF1; IL-4 | interleukin 4 |
TCMBANKGE000360 | CCNA2 | CCN1; CCNA | cyclin A2 |
TCMBANKGE000697 | APAF1 | APAF-1; CED4 | apoptotic peptidase activating factor 1 |
TCMBANKGE000788 | SELE | CD62E; ELAM; ELAM1; ESEL; LECAM2 | selectin E |
TCMBANKGE000921 | CCNB1 | CCNB | cyclin B1 |
TCMBANKGE001008 | CYP3A4 | CP33; CP34; CYP3A; CYP3A3; CYPIIIA3; CYPIIIA4; HLP; NF-25; P450C3; P450PCN1 | cytochrome P450 family 3 subfamily A member 4 |
TCMBANKGE001013 | BIRC5 | API4; EPR-1 | baculoviral IAP repeat containing 5 |
TCMBANKGE001045 | CCND1 | BCL1; D11S287E; PRAD1; U21B31 | cyclin D1 |
TCMBANKGE001069 | MPO | - | myeloperoxidase |
TCMBANKGE001073 | PTGS2 | COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 | prostaglandin-endoperoxide synthase 2 |
TCMBANKGE001085 | MAPK8 | JNK; JNK-46; JNK1; JNK1A2; JNK21B1/2; PRKM8; SAPK1; SAPK1c | mitogen-activated protein kinase 8 |
TCMBANKGE001132 | BAX | BCL2L4 | BCL2 associated X, apoptosis regulator |
TCMBANKGE001148 | VEGFA | MVCD1; VEGF; VPF | vascular endothelial growth factor A |
TCMBANKGE001156 | CASP3 | CPP32; CPP32B; SCA-1 | caspase 3 |
TCMBANKGE001161 | IL2 | IL-2; TCGF; lymphokine | interleukin 2 |
TCMBANKGE001166 | BCL2 | Bcl-2; PPP1R50 | BCL2 apoptosis regulator |
TCMBANKGE001169 | BCL2L1 | BCL-XL/S; BCL2L; BCLX; Bcl-X; PPP1R52 | BCL2 like 1 |
TCMBANKGE001176 | CAT | - | catalase |
TCMBANKGE001182 | SIRT1 | SIR2; SIR2L1; SIR2alpha | sirtuin 1 |
TCMBANKGE001184 | RELA | CMCU; NFKB3; p65 | RELA proto-oncogene, NF-kB subunit |
TCMBANKGE003210 | POLD1 | CDC2; CRCS10; MDPL; POLD | DNA polymerase delta 1, catalytic subunit |
TCMBANKGE004731 | ABCB5 | ABCB5alpha; ABCB5beta; EST422562 | ATP binding cassette subfamily B member 5 |
TCMBANKGE006248 | FCER2 | BLAST-2; CD23; CD23A; CLEC4J; FCE2; IGEBF | Fc fragment of IgE receptor II |
TCMBANKGE006368 | UGT1A1 | BILIQTL1; GNT1; HUG-BR1; UDPGT; UDPGT 1-1; UGT1; UGT1A | UDP glucuronosyltransferase family 1 member A1 |
TCMBANKGE008786 | CRAT | CAT; CAT1; NBIA8 | carnitine O-acetyltransferase |
TCMBANKGE009361 | GPT | AAT1; ALT1; GPT1 | glutamic--pyruvic transaminase |
TCMBANKGE012906 | PCDHAC2 | PCDH-ALPHA-C2 | protocadherin alpha subfamily C, 2 |
TCMBANKGE012983 | CSNK1A1 | CK1; CK1a; CKIa; HEL-S-77p; HLCDGP1; PRO2975 | casein kinase 1 alpha 1 |